Baxter International Dividend Details and Recent Developments Ahead of Ex-Dividend Date May 30, 2025

Baxter International has recently announced its upcoming dividend details. The company has set the ex-dividend date for May 30th, 2025, with the announcement made on May 6th, 2025. Shareholders will receive a dividend of $0.170 per share, payable on Jul 1st, 2025. This distribution is notably lower than the average of the last ten dividends, which stood at $0.238. Baxter's previous dividend, distributed on Apr 1st, 2025, was also $0.170 per share. These dividends are categorized as cash dividends, reflecting the company's consistent approach towards shareholder returns.

Recently, Baxter International Inc. has been in the news for several notable events. Over the past week, analysts have highlighted that the company's stock is approaching an ex-dividend date, which is critical for investors interested in receiving dividends. Furthermore, recent reports indicate that Morgan Stanley has lowered Baxter's price target from $30.00 to $28.00, assigning an "underweight" rating. This adjustment reflects a cautious outlook on the company's stock performance in the short term.

In addition to stock ratings, Baxter International continues to be recognized for its extensive portfolio of essential hospital products, including renal care solutions and sterile IV fluids. As of late, there has been interest in the company's stock options, with new puts and calls for September 2026 becoming available. These options provide investors with strategic opportunities to optimize returns through premium collection. The $27.50 put contract, for instance, offers a potential cost basis of $27.00, providing an attractive alternative to the current share price.

In conclusion, Baxter International's upcoming dividend is set for May 30th, 2025, marking the last day for investors to purchase shares and be eligible for this dividend distribution. Any acquisitions made after the ex-dividend date will not qualify for this period's dividend.